Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Hematopoietic Cell Transplantation (HCT) for Chemoradiotherapy-Related Myelodysplastic Syndrome and Acute Leukemia: A Single-Center Analysis of 47 Patients.

Hiroki Yokoyama, MD, Takahiro Fukuda, MD, Yukio Kobayashi, MD, Sung-Won Kim, MD, Dai Maruyama, MD, Shin-ichiro Mori, MD, Takashi Watanabe, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PHD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 5055.

https://doi.org/10.1182/blood.V110.11.5055.5055

Published: 2007

Journal Articles

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Bungo Saito, MD, Takahiro Fukuda, MD, Hiroki Yokoyama, MD, Saiko Kurosawa, MD, Toshihiro Takahashi, MD, Shigeo Fuji, MD, Noriko Takahashi, Kinuko Tajima, PhD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD, Yuji Heike, MD

Blood (2007) 110 (11): 2009.

https://doi.org/10.1182/blood.V110.11.2009.2009

Published: 2007

Journal Articles

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Eiji Usui, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2015.

https://doi.org/10.1182/blood.V106.11.2015.2015

Published: 2005

Journal Articles

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Ruri Kato, MD, Takahiro Fukuda, MD, Eiji Usui, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2731.

https://doi.org/10.1182/blood.V106.11.2731.2731

Published: 2005

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Dai Maruyama, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Eiji Usui, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 1142.

https://doi.org/10.1182/blood.V106.11.1142.1142

Published: 2005

NARROW

Hematopoietic Cell Transplantation (HCT) for Chemoradiotherapy-Related Myelodysplastic Syndrome and Acute Leukemia: A Single-Center Analysis of 47 Patients.

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Email alerts

ASH Publications

American Society of Hematology

Hematopoietic Cell Transplantation (HCT) for Chemoradiotherapy-Related Myelodysplastic Syndrome and Acute Leukemia: A Single-Center Analysis of 47 Patients.

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only